drugIndia
Cart
Glycihal 1GV Tablet SR

Glycihal 1GV Tablet SR

Metformin (500mg) + Glimepiride (1mg) + Voglibose (0.2mg)

Halden Healthcare & Research Pvt Ltd
Narcolepsy
90.00112.5020% OFF
In Stock
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
drugIndia verified
Save 65%
Best Alternative100% Match

Glimison-VM 1 Tablet SR

Unison Pharmaceuticals Pvt Ltd

Voglibose 0.2mg
Glimison-VM 1 Tablet SR

Pack Size

1 units

Price

31.6020% off
Glimison-VM 1 Tablet SR is 100% same as Glycihal 1GV Tablet SR
Better ValueSame QualitySame Effectiveness

Save ₹58

that's 65% off!

composition
  1. Voglibose 0.2mg
  2. Glimepiride 1mg
  3. Metformin 500mg
Buy Now
90.0020% OFF
112.50

About This Medicine

Product description & overview

Glycihal 1GV Tablet SR: A Combination Therapy for Blood Sugar Management

Glycihal 1GV Tablet SR combines a trio of powerful diabetes medications for comprehensive blood sugar control. Each tablet delivers the following:

* Glimepiride (1mg): A sulfonylurea that stimulates insulin secretion from beta cells, effectively lowering glucose levels.
* Metformin (500mg): A first-line antidiabetic drug that reduces hepatic glucose production and enhances insulin sensitivity, ultimately improving blood sugar regulation.
* Voglibose (0.2mg): This alpha-glucosidase inhibitor slows the absorption of carbohydrates from the intestines, further preventing rapid spikes in blood glucose after meals.

Glycihal 1GV Tablet SR is formulated for sustained release, ensuring consistent blood sugar control throughout the day. It is designed for patients with Type 2 diabetes who require combined treatment. Always consult your healthcare professional before initiating or altering any medication regimen.

Disclaimer: This description is provided for informational purposes only and should not be considered medical advice. Consult a qualified healthcare professional for personalized guidance regarding your specific health condition.

Active composition

Metformin 500 mg

+2 more active ingredients

About Metformin

Metformin is an oral antihyperglycemic agent used to manage type 2 diabetes mellitus. It works by decreasing glucose production in the liver and improving insulin sensitivity. Metformin is effective in controlling blood sugar levels and preventing diabetes-related complications. In summary, Metformin is vital for managing type 2 diabetes.

How It Works

Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.

Medicine Strength
500 mg

All Active Ingredients

Metformin500 mg
Glimepiride1 mg
Voglibose0.2 mg

Glimepiride

Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.

Voglibose

Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.

Dosage & How to Use

Dosage information not available. Please consult your doctor or pharmacist.

Safety Advice

Important precautions

Side Effect Occurrence

Based on clinical trials and patient reports.

Overall Tolerance

Most patients tolerate well

Only 2.3% reported effects

Common Side Effects

Headache8%
Nausea5%
Dizziness3%
Fatigue2%
Rash1%
Higher
Lower

Safety Advice

Alcohol

It is unsafe to consume alcohol with Glycihal 1GV Tablet SR.

High Risk

Pregnancy

Glycihal 1GV Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Medical Advice

Driving

Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.

Exercise Caution

Liver

Glycihal 1GV Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Glycihal 1GV Tablet SR may be needed. Please consult your doctor. Glycihal 1GV Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.

Regular Checkup

Breastfeeding

Glycihal 1GV Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Consult Doctor

Kidney

Glycihal 1GV Tablet SR is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Glycihal 1GV Tablet SR is, however, not recommended in patients with severe kidney disease.

Regular Checkup

Customer Reviews

0 reviews for Glycihal 1GV Tablet SR

Products matching your search